NU58DP007345
Cooperative Agreement
Overview
Grant Description
NJ Diabetes Prevention and Control Program through Advancing Health Equity for Priority Populations
Diabetes is a significant public health concern. In New Jersey, diabetes was the eighth leading cause of death in 2020 (2020 Death Data, National Vital Statistics System via CDC WONDER and rankings and rates are based on 2020 age-adjusted death rates). Age-adjusted diabetes prevalence estimates for the adult population in New Jersey nearly doubled since 1993 (4.3% in 1993 to 8.5% in 2020). The rising prevalence of diabetes is a public health concern, as diabetes is also known to be a major risk factor for heart disease and stroke, as well as the leading cause of kidney failure, non-traumatic lower limb amputations, and new cases of blindness in the United States (CDC: https://www.cdc.gov/diabetes/professional-info/toolkits/new-beginnings/index.html).
The New Jersey Department of Health (NJDOH) will address the burden of diabetes through statewide, population-based, evidence-based system interventions. The Diabetes Prevention and Control Program (NJDPCP) will address the burden of diabetes by implementing prevention and self-management strategies (Diabetes Prevention Program, Diabetes Self-Management Education and Support), system-level multi-directional e-referral systems, strengthening the infrastructure to expand community health worker involvement in diabetes prevention and management programs, and improving the capacity of the diabetes workforce to address social determinants of health (SDOH).
NJDPCP staff identified priority populations by assessing the prevalence of diabetes and obesity at the county level, further broken down by demographic variables. New Jersey has a diabetes prevalence of 8.5%, and the following (of New Jersey's 21) counties have a prevalence higher than 8.5% and are being identified as priority: Atlantic, Burlington, Camden, Cumberland, Hudson, Mercer, Middlesex, Passaic, Salem, and Sussex. Salem, Cumberland, Gloucester, and Camden have the highest adult prevalence for obesity (2017-2020) at 36% and higher.
Diabetes is a significant public health concern. In New Jersey, diabetes was the eighth leading cause of death in 2020 (2020 Death Data, National Vital Statistics System via CDC WONDER and rankings and rates are based on 2020 age-adjusted death rates). Age-adjusted diabetes prevalence estimates for the adult population in New Jersey nearly doubled since 1993 (4.3% in 1993 to 8.5% in 2020). The rising prevalence of diabetes is a public health concern, as diabetes is also known to be a major risk factor for heart disease and stroke, as well as the leading cause of kidney failure, non-traumatic lower limb amputations, and new cases of blindness in the United States (CDC: https://www.cdc.gov/diabetes/professional-info/toolkits/new-beginnings/index.html).
The New Jersey Department of Health (NJDOH) will address the burden of diabetes through statewide, population-based, evidence-based system interventions. The Diabetes Prevention and Control Program (NJDPCP) will address the burden of diabetes by implementing prevention and self-management strategies (Diabetes Prevention Program, Diabetes Self-Management Education and Support), system-level multi-directional e-referral systems, strengthening the infrastructure to expand community health worker involvement in diabetes prevention and management programs, and improving the capacity of the diabetes workforce to address social determinants of health (SDOH).
NJDPCP staff identified priority populations by assessing the prevalence of diabetes and obesity at the county level, further broken down by demographic variables. New Jersey has a diabetes prevalence of 8.5%, and the following (of New Jersey's 21) counties have a prevalence higher than 8.5% and are being identified as priority: Atlantic, Burlington, Camden, Cumberland, Hudson, Mercer, Middlesex, Passaic, Salem, and Sussex. Salem, Cumberland, Gloucester, and Camden have the highest adult prevalence for obesity (2017-2020) at 36% and higher.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
New Jersey
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 200% from $1,200,000 to $3,600,000.
New Jersey Department Of Health was awarded
NJ Diabetes Prevention : Advancing Health Equity Priority Populations
Cooperative Agreement NU58DP007345
worth $3,600,000
from National Center for Chronic Disease Prevention and Health Promotion in June 2023 with work to be completed primarily in New Jersey United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.988 Cooperative Agreements for State-Based Diabetes Control Programs and Evaluation of Surveillance Systems.
The Cooperative Agreement was awarded through grant opportunity A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.
Status
(Ongoing)
Last Modified 7/3/25
Period of Performance
6/30/23
Start Date
6/29/28
End Date
Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU58DP007345
Transaction History
Modifications to NU58DP007345
Additional Detail
Award ID FAIN
NU58DP007345
SAI Number
NU58DP007345-3673705233
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CUC0 CDC NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION
Awardee UEI
MQKPEU6D1BT5
Awardee CAGE
3MWJ7
Performance District
NJ-90
Senators
Robert Menendez
Cory Booker
Cory Booker
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Health and Human Services (075-0948) | Health care services | Grants, subsidies, and contributions (41.0) | $1,200,000 | 100% |
Modified: 7/3/25